About The Oncologist^®

MISSION AND BELIEFS

The practice of oncology and hematology is more challenging than ever before. Physicians are charting new territories in cancer patient care and practice management. The Oncologist^® was established by oncologists to help physicians better manage their practices in a changing and challenging environment—to guard against the future and ensure their patient's rights to the best health care possible.

The Oncologist is devoted to medical and practice issues for surgical, radiation, and medical oncologists and is designed specifically for the busy practitioner entrusted with the care of adult or pediatric cancer patients. With emphasis on clear, concise interpretation, this international peer-reviewed journal publishes original papers, reviews, and commentaries addressing the multimodality diagnosis, treatment, and quality of life of the cancer patient. Manuscripts are reviewed by two or more experts in the field and, when accepted, are published with haste—generally within 12 weeks. When a contribution is of such relevance as to significantly impact public health, authors may request Fast Track Review for a Rapid Communication, in which case an editorial decision will be made within 2 weeks of submission.

The journal's articles are meant to impact the practice of oncology and to facilitate significant communication in the introduction of new medical treatments and technologies. Emphasizing the interpretation rather than the data, The Oncologist's Senior Editors believe that the various oncology subspecialists should share the same information base and read the same journal. As cancer specialists, we should resist the trend to capitulate our responsibilities in disease management to payers, gatekeepers, and hospital administrators. It is up to us to defend the patient's needs and rights and to assure that the patient has an advocate. In order to do so, we have to be united and fully informed. We pledge to put the best and latest information on cancer management before our readership, to help prepare them for the future, and to do their best as a team for every patient.

To this end, The Oncologist challenges its readers to understand what is new and better, to glimpse the future, not only in terms of research, but also in terms of new team approaches to disease management. In short, we want our readers to explore how cancer medicine could be and will be practiced now and throughout the 21st century.

CORRESPONDENCE

Editorial correspondence, including submissions for publication or letters to the Editor, should be addressed to the Martin.Murphy{at}TheOncologist.com. Submissions for publication in the Fundamentals in Cancer Medicine section should also be addressed to the Executive Editor.

Information for Authors can be found at the back of each issue, or contact the AlphaMed Press Editorial Office.

Advertising: Correspondence and rate requests should be addressed to the Publisher.

Change of Address notices: Both the subscriber's old and new address should be e-mailed to TheOncologist{at}cambeywest.com at least one month in advance. You can also mail the information to: AlphaMed Press, c/o Cambey & West, PO Box 412, Congers, New York 10920-9914 USA.

Disclaimer: While the publisher and Editorial Board make every effort to see that no inaccurate or misleading data, opinion, or statement appear in this journal, they wish to state that the data and opinions in the articles and advertisements herein are the responsibility of the contributor or advertiser concerned. Accordingly, the publisher, Editorial Board, and their respective employees, officers, and agents accept no liability whatsoever for the consequences of any such inaccurate or misleading data, opinion, or statement. While every effort is made to ensure drug doses and other quantities are presented accurately, readers are advised that new methods and techniques involving drug usage described within this journal should only be followed in conjunction with the drug manufacturer's own published literature. It is the responsibility of the treating physician or other health care professional, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient. This is particularly serious if the agent to be administered is a new one or one that is infrequently used. Because of the uniqueness of each patient and the need to take into account a number of concurrent considerations, this information should be used by physicians only as a general guide to determining the best treatment for each patient.

The Oncologist Journal is regularly indexed by Index Medicus/MEDLINE, EMBASE/Excerpta Medica, Chemical Abstracts, Biology Digest, Cumulative Index to Nursing and Allied Health Literature^® print index and database.

The Oncologist Journal is printed in the United States of America on paper that meets ANSI/NISO Z39.48-1992 requirements and adheres to library/archival stability.

The Oncologist^® (pISSN: 1083-7159) (eISSN: 1549-490X) is published monthly by AlphaMed Press, 318 Blackwell Street, Suite 260, Durham, North Carolina 27701 USA; AlphaMed Europe Limited, Almac House, 20 Seagoe Industrial Estate, Craigavon BT63 5QD, Northern Ireland, NI053473.